Perspective
Published on 25 Aug 2022
Current Status and Prospects of Research on Ischemia-Reperfusion Injury and Ferroptosis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.920707
- 3,085 views
- 4 citations
Type at least 3 characters
2,924 articles
Articles
Original Research
Published on 25 Aug 2022
Substrate stiffness effect on molecular crosstalk of epithelial-mesenchymal transition mediators of human glioblastoma cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.983507
- 3,355 views
- 4 citations
Review
Published on 25 Aug 2022
Neutrophils: Musketeers against immunotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.975981
- 6,888 views
- 19 citations
Study Protocol
Published on 24 Aug 2022
POD1UM-303/InterAACT 2: A phase III, global, randomized, double-blind study of retifanlimab or placebo plus carboplatin–paclitaxel in patients with locally advanced or metastatic squamous cell anal carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.935383
- 5,203 views
- 9 citations
Original Research
Published on 24 Aug 2022
Suppressor of fused associates with dissemination patterns in patients with glioma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.923681
- 1,471 views
Study Protocol
Published on 24 Aug 2022
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.918499
- 2,578 views
- 3 citations
Original Research
Published on 24 Aug 2022
The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.942386
- 3,622 views
- 9 citations
Original Research
Published on 23 Aug 2022
Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.926260
- 2,807 views
- 8 citations
Original Research
Published on 23 Aug 2022
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.983887
- 3,649 views
- 5 citations
General Commentary
Published on 22 Aug 2022
Commentary: High-metastatic melanoma cells promote the metastatic capability of low-metastatic melanoma cells via exosomal transfer of miR-411-5p
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.957035
- 1,391 views
- 1 citation
Original Research
Published on 19 Aug 2022
LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.949951
- 2,424 views
- 8 citations
Original Research
Published on 18 Aug 2022
Drug-induced tumor-specific cytotoxicity in a whole tissue ex vivo model of human pancreatic ductal adenocarcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.965182
- 4,200 views
- 7 citations
Original Research
Published on 18 Aug 2022
miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.945057
- 2,959 views
- 9 citations
Review
Published on 18 Aug 2022
Degradation strategy of cyclin D1 in cancer cells and the potential clinical application
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.949688
- 7,204 views
- 18 citations
Original Research
Published on 18 Aug 2022
Circ0038632 modulates MiR-186/DNMT3A axis to promote proliferation and metastasis in osteosarcoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.939994
- 1,495 views
- 4 citations
Original Research
Published on 18 Aug 2022
Decellularization of xenografted tumors provides cell-specific in vitro 3D environment
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.956940
- 3,797 views
- 6 citations